New User:

-or-
Username:
Password:
Forgot your password?
News Breaks
October 29, 2009
16:14 EDTDVAX
theflyonthewall.com: Dynavax's Phase III Heplisav study shows increased kidney protection
Dynavax Technologies will show phase 3 clinical data for Heplisav investigational Hepatitis B vaccine in chronic kidney disease patients at the Infectious Disease Society of America annual meeting on 31 October. Patients demonstrated increased protection against hepatitis B in fewer doses than patients receiving licensed vaccine. :theflyonthewall.com



News For DVAX From The Last 14 Days
Check below for free stories on DVAX the last two weeks.
There are 3 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 13, 2012
09:05 EDTDVAX
theflyonthewall.com: Dynavax Heplislav Phase lll data published in Vaccine

Subscribe for More Information
:theflyonthewall.com

February 2, 2012
12:56 EDTDVAX
theflyonthewall.com: Dynavax expanded Heplisav label a significant positive, says William Blair

Subscribe for More Information
:theflyonthewall.com
10:17 EDTDVAX
theflyonthewall.com: Dynavax should seek broad label for Heplisav, says Cowen

Subscribe for More Information
:theflyonthewall.com